Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Endometrial cancer is the most common malignancy of the female genital tract in developed countries. To identify genetic variants associated with endometrial cancer risk, we performed a genome-wide association study involving 1,265 individuals with endometrial cancer (cases) from Australia and the UK and 5,190 controls from the Wellcome Trust Case Control Consortium. We compared genotype frequencies in cases and controls for 519,655 SNPs. Forty seven SNPs that showed evidence of association with endometrial cancer in stage 1 were genotyped in 3,957 additional cases and 6,886 controls. We identified an endometrial cancer susceptibility locus close to HNF1B at 17q12 (rs4430796, P = 7.1 × 10(-10)) that is also associated with risk of prostate cancer and is inversely associated with risk of type 2 diabetes.

Original publication

DOI

10.1038/ng.812

Type

Journal article

Journal

Nat Genet

Publication Date

05/2011

Volume

43

Pages

451 - 454

Keywords

Adolescent, Adult, Aged, Aged, 80 and over, Case-Control Studies, Diabetes Mellitus, Type 2, Endometrial Neoplasms, Female, Genetic Predisposition to Disease, Genetic Variation, Genome-Wide Association Study, Hepatocyte Nuclear Factor 1-beta, Humans, Male, Middle Aged, Odds Ratio, Polymorphism, Single Nucleotide, Prostatic Neoplasms, Risk Factors, Young Adult